Hyderabad Pharma Units Shut Down in Fentanyl-Linked Probe
In a significant enforcement action, the Telangana Pollution Control Board (TGPCB) has ordered the closure of three pharmaceutical and chemical units operating in and around Hyderabad. The crackdown, which also involved disconnecting the power supply to these facilities, comes amid an intensifying multi-agency investigation into the manufacture of chemicals linked to fentanyl, a potent opioid drug.
Multi-Agency Scrutiny Targets Non-Compliant Operations
Multiple agencies, including the Telangana Anti-Narcotics Bureau (TGNAB), TGPCB, Narcotics Control Bureau, and Directorate of Revenue Intelligence, are examining the activities of closed units, those operating without mandatory consent, and small-scale operators suspected of manufacturing precursor chemicals different from their permitted products. This scrutiny has sharpened following a US indictment filed last year against a Hyderabad-based pharmaceutical company and its promoter for alleged involvement in supplying fentanyl precursor chemicals to the US market.
US Indictment Details International Dimension
The investigation gained urgency due to an international context highlighted by a March 20, 2025, indictment filed in a US District of Columbia court. This indictment names a city-based pharma company and three senior executives in a criminal case involving the alleged manufacture and distribution of N-BOC-4-piperidone, a listed chemical described as a building block for fentanyl. According to details from the indictment, the US Drug Enforcement Administration's (DEA) undercover investigation between March and November 2024 documented controlled sales and proforma invoices for shipments intended for locations in the United States and Mexico.
Enforcement Actions and Broader Implications
The clearest enforcement action so far occurred on Tuesday when TGPCB, acting on inputs from TGNAB, ordered the closure of the three units and directed the disconnection of their power supply. This move underscores the broader implications of the probe, linking local regulatory compliance with global narcotics trafficking concerns. The focus on closed and non-compliant units aims to curb potential illicit activities that could contribute to the international fentanyl crisis, emphasizing the role of environmental and narcotics agencies in collaborative efforts.
